Advertisement

Genetics of Female Infertility Due to Anomalies of the Ovary and Mullerian Ducts

  • Joe Leigh Simpson
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1154)

Abstract

Genetic factors are pivotal in reproductive development and subsequent reproductive processes. If disturbed, infertility can occur. In the female, genetic factors affecting the ovary and the uterus are not uncommon causes of infertility. Terminal deletions on the X long arm and X short arm and X chromosomal mosaicism have long been accepted as causes of premature ovarian failure (POF). Responsible genes on the X have not yet elucidated. Attractive candidate genes for POF also exist on autosomes, and in over a dozen genes molecular perturbations are documented in non-syndromic POF. The most common single-gene cause of POF is premutation carriers for FMR1 (fragile X syndrome). As other candidate genes and additional ethnic groups are interrogated, the proportion of POF cases due to single-gene mutation will increase. Among uterine anomalies, incomplete mullerian fusion is most common. Increased recurrence risks for first-degree relatives confirm a role for genetic factors; interrogation of candidate genes is under way.

Key words

Premature ovarian failure X-chromosome deletions Single genes Mutation Candidate genes Genetic heterogeneity Incomplete mullerian fusion Mullerian aplasia Array CGH 

References

  1. 1.
    Simpson JL (2012) Disorders of the gonads, genital tract and genitalia, 6th edn. Churchill-Livingstone, New York, NYGoogle Scholar
  2. 2.
    Jost A (1966) Problems of fetal endocrinology: the adrenal glands. Recent Prog Horm Res 22:541–574PubMedGoogle Scholar
  3. 3.
    Schlessinger D, Garcia-Ortiz JE, Forabosco A, Uda M, Crisponi L, Pelosi E (2010) Determination and stability of gonadal sex. J Androl 31:16–25PubMedCentralPubMedGoogle Scholar
  4. 4.
    Uhlenhaut NH, Jakob S, Anlag K, Eisenberger T, Sekido R, Kress J, Treier AC, Klugmann C, Klasen C, Holter NI, Riethmacher D, Schutz G, Cooney AJ, Lovell-Badge R, Treier M (2009) Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 139:1130–1142PubMedGoogle Scholar
  5. 5.
    Fraccaro M, Maraschio P, Pasquali F, Scappaticci S (1977) Women heterozygous for deficiency of the (p21 leads to pter) region of the X chromosome are fertile. Hum Genet 39:283–292PubMedGoogle Scholar
  6. 6.
    Simpson JL (1986) Phenotypic-karyotypic correlations of gonadal determinants: current status and relationship to molecular studies. In: Sperling KVF (ed) Seventh international congress on human genetics. Springer, Berlin, pp 224–232Google Scholar
  7. 7.
    Simpson JL (1989) Genetic heterogeneity in XY sex reversal. Potential pitfalls in isolating the testis-determining-factor (TDF). In: Wachtel S (ed) Evolutionary mechanisms in sex determination. CRC, Baton Rouge, LAGoogle Scholar
  8. 8.
    Simpson JL (1988) Genetics of sex determination. In: Iizuka R, Semm K, Ohno T (eds) Human reproduction: current status, future prospect. Proceedings of VIth World Congress on Human Reproduction. Elsevier Science, AmsterdamGoogle Scholar
  9. 9.
    Simpson JL, Elias S (2003) Genetics in obstetrics and gynecology, 3rd edn. WB Saunders, PhiladelphiaGoogle Scholar
  10. 10.
    Simpson JL, Lebeau MM (1981) Gonadal and statural determinants on the X chromosome and their relationship to in vitro studies showing prolonged cell cycles in 45, X; 46, X, del(X)(p11); 46, X, del(X)(q13); and 46, X, del(X)(q22) fibroblasts. Am J Obstet Gynecol 141:930–940PubMedGoogle Scholar
  11. 11.
    Ogata T, Matsuo N (1995) Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet 95:607–629PubMedGoogle Scholar
  12. 12.
    Simpson JL (2000) Genetic programming in ovarian development and oogenesis. In: Lobo RA, Kelsey J, Marcus R (eds) Menopause biology and pathobiology. Academic, LondonGoogle Scholar
  13. 13.
    Simpson JL, Rajkovic A (1999) Ovarian differentiation and gonadal failure. Am J Med Genet 89:186–200PubMedGoogle Scholar
  14. 14.
    Fitch N, de Saint Victor J, Richer CL, Pinsky L, Sitahal S (1982) Premature menopause due to a small deletion in the long arm of the X chromosome: a report of three cases and a review. Am J Obstet Gynecol 142:968–972PubMedGoogle Scholar
  15. 15.
    Krauss CM, Turksoy RN, Atkins L, McLaughlin C, Brown LG, Page DC (1987) Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. N Engl J Med 317:125–131PubMedGoogle Scholar
  16. 16.
    Tharapel AT, Anderson KP, Simpson JL, Martens PR, Wilroy RS Jr, Llerena JC Jr, Schwartz CE (1993) Deletion (X)(q26.1→q28) in a proband and her mother: molecular characterization and phenotypic-karyotypic deductions. Am J Hum Genet 52:463–471PubMedCentralPubMedGoogle Scholar
  17. 17.
    Matzuk MM, Lamb DJ (2008) The biology of infertility: research advances and clinical challenges. Nat Med 14:1197–1213PubMedCentralPubMedGoogle Scholar
  18. 18.
    Ochalski ME, Engle N, Wakim A, Ravnan BJ, Hoffner L, Rajkovic A, Surti U (2011) Complex X chromosome rearrangement delineated by array comparative genome hybridization in a woman with premature ovarian insufficiency. Fertil Steril 95(2433):e2439–2415Google Scholar
  19. 19.
    Kok HS, van Asselt KM, van der Schouw YT, Peeters PH, Wijmenga C (2005) Genetic studies to identify genes underlying menopausal age. Hum Reprod Update 11:483–493PubMedGoogle Scholar
  20. 20.
    Stolk L, Zhai G, van Meurs JB, Verbiest MM, Visser JA, Estrada K, Rivadeneira F, Williams FM, Cherkas L, Deloukas P, Soranzo N, de Keyzer JJ, Pop VJ, Lips P, Lebrun CE, van der Schouw YT, Grobbee DE, Witteman J, Hofman A, Pols HA, Laven JS, Spector TD, Uitterlinden AG (2009) Loci at chromosomes 13, 19 and 20 influence age at natural menopause. Nat Genet 41:645–647PubMedCentralPubMedGoogle Scholar
  21. 21.
    Christin-Maitre S, Tachdjian G (2010) Genome-wide association study and premature ovarian failure. Ann Endocrinol (Paris) 71:218–221Google Scholar
  22. 22.
    He C, Kraft P, Chen C, Buring JE, Pare G, Hankinson SE, Chanock SJ, Ridker PM, Hunter DJ, Chasman DI (2009) Genome-wide association studies identify loci associated with age at menarche and age at natural menopause. Nat Genet 41:724–728PubMedCentralPubMedGoogle Scholar
  23. 23.
    Murray A, Bennett CE, Perry JR, Weedon MN, Jacobs PA, Morris DH, Orr N, Schoemaker MJ, Jones M, Ashworth A, Swerdlow AJ (2011) Common genetic variants are significant risk factors for early menopause: results from the Breakthrough Generations Study. Hum Mol Genet 20:186–192PubMedCentralPubMedGoogle Scholar
  24. 24.
    Knauff EA, Franke L, van Es MA, van den Berg LH, van der Schouw YT, Laven JS, Lambalk CB, Hoek A, Goverde AJ, Christin-Maitre S, Hsueh AJ, Wijmenga C, Fauser BC (2009) Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum Reprod 24:2372–2378PubMedGoogle Scholar
  25. 25.
    Knauff EA, Blauw HM, Pearson PL, Kok K, Wijmenga C, Veldink JH, van den Berg LH, Bouchard P, Fauser BC, Franke L (2011) Copy number variants on the X chromosome in women with primary ovarian insufficiency. Fertil Steril 95(1584–1588):e1581Google Scholar
  26. 26.
    Dudding TE, Lawrence O, Winship I, Froyen G, Vandewalle J, Scott R, Shelling AN (2010) Array comparative genomic hybridization for the detection of submicroscopic copy number variations of the X chromosome in women with premature ovarian failure. Hum Reprod 25:3159–3160, author reply 3160–3151PubMedGoogle Scholar
  27. 27.
    Aboura A, Dupas C, Tachdjian G, Portnoi MF, Bourcigaux N, Dewailly D, Frydman R, Fauser B, Ronci-Chaix N, Donadille B, Bouchard P, Christin-Maitre S (2009) Array comparative genomic hybridization profiling analysis reveals deoxyribonucleic acid copy number variations associated with premature ovarian failure. J Clin Endocrinol Metab 94:4540–4546PubMedGoogle Scholar
  28. 28.
    Quilter CR, Karcanias AC, Bagga MR, Duncan S, Murray A, Conway GS, Sargent CA, Affara NA (2010) Analysis of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF). Hum Reprod 25:2139–2150PubMedGoogle Scholar
  29. 29.
    Jones MH, Furlong RA, Burkin H, Chalmers IJ, Brown GM, Khwaja O, Affara NA (1996) The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2. Hum Mol Genet 5:1695–1701PubMedGoogle Scholar
  30. 30.
    Luoh SW, Bain PA, Polakiewicz RD, Goodheart ML, Gardner H, Jaenisch R, Page DC (1997) Zfx mutation results in small animal size and reduced germ cell number in male and female mice. Development 124:2275–2284PubMedGoogle Scholar
  31. 31.
    Hanrahan JP, Gregan SM, Mulsant P, Mullen M, Davis GH, Powell R, Galloway SM (2004) Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol Reprod 70:900–909PubMedGoogle Scholar
  32. 32.
    Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ, Matzuk MM (1998) The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 12:1809–1817PubMedGoogle Scholar
  33. 33.
    Hanevik HI, Hilmarsen HT, Skjelbred CF, Tanbo T, Kahn JA (2011) A single nucleotide polymorphism in BMP15 is associated with high response to ovarian stimulation. Reprod Biomed Online 23:97–104PubMedGoogle Scholar
  34. 34.
    Di Pasquale E, Beck-Peccoz P, Persani L (2004) Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 75:106–111PubMedCentralPubMedGoogle Scholar
  35. 35.
    Dixit H, Rao LK, Padmalatha VV, Kanakavalli M, Deenadayal M, Gupta N, Chakrabarty B, Singh L (2006) Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet 119:408–415PubMedGoogle Scholar
  36. 36.
    Laissue P, Christin-Maitre S, Touraine P, Kuttenn F, Ritvos O, Aittomaki K, Bourcigaux N, Jacquesson L, Bouchard P, Frydman R, Dewailly D, Reyss AC, Jeffery L, Bachelot A, Massin N, Fellous M, Veitia RA (2006) Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol 154:739–744PubMedGoogle Scholar
  37. 37.
    Zhang P, Shi YH, Wang LC, Chen ZJ (2007) Sequence variants in exons of the BMP-15 gene in Chinese patients with premature ovarian failure. Acta Obstet Gynecol Scand 86:585–589PubMedGoogle Scholar
  38. 38.
    Ellison JW, Wardak Z, Young MF, Gehron Robey P, Laig-Webster M, Chiong W (1997) PHOG, a candidate gene for involvement in the short stature of Turner syndrome. Hum Mol Genet 6:1341–1347PubMedGoogle Scholar
  39. 39.
    Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, Rappold GA (1997) Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet 16:54–63PubMedGoogle Scholar
  40. 40.
    Belin V, Cusin V, Viot G, Girlich D, Toutain A, Moncla A, Vekemans M, Le Merrer M, Munnich A, Cormier-Daire V (1998) SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet 19:67–69PubMedGoogle Scholar
  41. 41.
    Shears DJ, Vassal HJ, Goodman FR, Palmer RW, Reardon W, Superti-Furga A, Scambler PJ, Winter RM (1998) Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis. Nat Genet 19:70–73PubMedGoogle Scholar
  42. 42.
    Tachdjian G, Aboura A, Portnoi MF, Pasquier M, Bourcigaux N, Simon T, Rousseau G, Finkel L, Benkhalifa M, Christin-Maitre S (2008) Cryptic Xp duplication including the SHOX gene in a woman with 46, X, del(X)(q21.31) and premature ovarian failure. Hum Reprod 23:222–226PubMedGoogle Scholar
  43. 43.
    Castrillon DH, Wasserman SA (1994) Diaphanous is required for cytokinesis in Drosophila and shares domains of similarity with the products of the limb deformity gene. Development 120:3367–3377PubMedGoogle Scholar
  44. 44.
    Bione S, Sala C, Manzini C, Arrigo G, Zuffardi O, Banfi S, Borsani G, Jonveaux P, Philippe C, Zuccotti M, Ballabio A, Toniolo D (1998) A human homologue of the Drosophila melanogaster diaphanous gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet 62:533–541PubMedCentralPubMedGoogle Scholar
  45. 45.
    Mumm S, Herrera L, Waeltz PW, Scardovi A, Nagaraja R, Esposito T, Schlessinger D, Rocchi M, Forabosco A (2001) X/autosomal translocations in the Xq critical region associated with premature ovarian failure fall within and outside genes. Genomics 76:30–36PubMedGoogle Scholar
  46. 46.
    Prueitt RL, Chen H, Barnes RI, Zinn AR (2002) Most X;autosome translocations associated with premature ovarian failure do not interrupt X-linked genes. Cytogenet Genome Res 97:32–38PubMedGoogle Scholar
  47. 47.
    Riva P, Magnani I, Fuhrmann Conti AM, Gelli D, Sala C, Toniolo D, Larizza L (1996) FISH characterization of the Xq21 breakpoint in a translocation carrier with premature ovarian failure. Clin Genet 50:267–269PubMedGoogle Scholar
  48. 48.
    Lacombe A, Lee H, Zahed L, Choucair M, Muller JM, Nelson SF, Salameh W, Vilain E (2006) Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure. Am J Hum Genet 79:113–119PubMedCentralPubMedGoogle Scholar
  49. 49.
    Bione S, Rizzolio F, Sala C, Ricotti R, Goegan M, Manzini MC, Battaglia R, Marozzi A, Vegetti W, Dalpra L, Crosignani PG, Ginelli E, Nappi R, Bernabini S, Bruni V, Torricelli F, Zuffardi O, Toniolo D (2004) Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B. Hum Reprod 19:2759–2766PubMedGoogle Scholar
  50. 50.
    Padovano V, Lucibello I, Alari V, Della Mina P, Crespi A, Ferrari I, Recagni M, Lattuada D, Righi M, Toniolo D, Villa A, Pietrini G (2011) The POF1B candidate gene for premature ovarian failure regulates epithelial polarity. J Cell Sci 124:3356–3368PubMedGoogle Scholar
  51. 51.
    Katsuya T, Horiuchi M, Minami S, Koike G, Santoro NF, Hsueh AJ, Dzau VJ (1997) Genomic organization and polymorphism of human angiotensin II type 2 receptor: no evidence for its gene mutation in two families of human premature ovarian failure syndrome. Mol Cell Endocrinol 127:221–228PubMedGoogle Scholar
  52. 52.
    Bione S, Toniolo D (2000) X chromosome genes and premature ovarian failure. Semin Reprod Med 18:51–57PubMedGoogle Scholar
  53. 53.
    Prueitt RL, Ross JL, Zinn AR (2000) Physical mapping of nine Xq translocation breakpoints and identification of XPNPEP2 as a premature ovarian failure candidate gene. Cytogenet Cell Genet 89:44–50PubMedGoogle Scholar
  54. 54.
    Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, Corrigan EC, Simpson JL, Nelson LM (2007) The FMR1 premutation and reproduction. Fertil Steril 87:456–465PubMedGoogle Scholar
  55. 55.
    Schwartz CE, Dean J, Howard-Peebles PN, Bugge M, Mikkelsen M, Tommerup N, Hull C, Hagerman R, Holden JJ, Stevenson RE (1994) Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet 51:400–402PubMedGoogle Scholar
  56. 56.
    Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, Hudson R, Gorwill H, Nolin SL, Glicksman A, Jenkins EC, Brown WT, Howard-Peebles PN, Becchi C, Cummings E, Fallon L, Seitz S, Black SH, Vianna-Morgante AM, Costa SS, Otto PA, Mingroni-Netto RC, Murray A, Webb J, Vieri F et al (1999) Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study–preliminary data. Am J Med Genet 83:322–325PubMedCentralPubMedGoogle Scholar
  57. 57.
    Sullivan AK, Marcus M, Epstein MP, Allen EG, Anido AE, Paquin JJ, Yadav-Shah M, Sherman SL (2005) Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod 20:402–412PubMedGoogle Scholar
  58. 58.
    Foresta C, Ferlin A, Gianaroli L, Dallapiccola B (2002) Guidelines for the appropriate use of genetic tests in infertile couples. Eur J Hum Genet 10:303–312PubMedGoogle Scholar
  59. 59.
    Simpson JL, Christakos AC, Horwith M, Silverman FS (1971) Gonadal dysgenesis in individuals with apparently normal chromosomal complements: tabulation of cases and compilation of genetic data. Birth Defects Orig Artic Ser 7:215–228PubMedGoogle Scholar
  60. 60.
    Simpson JL (1979) Gonadal dysgenesis and sex chromosome abnormalities. Phenotypic/karyotypic correlations. In: Vallet HL, Porter IH (eds) Genetic mechanisms of sexual development. Academic, New York, NYGoogle Scholar
  61. 61.
    Aittomaki K (1994) The genetics of XX gonadal dysgenesis. Am J Hum Genet 54:844–851PubMedCentralPubMedGoogle Scholar
  62. 62.
    Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, Kaskikari R, Sankila EM, Lehvaslaiho H, Engel AR, Nieschlag E, Huhtaniemi I, de la Chapelle A (1995) Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82:959–968PubMedGoogle Scholar
  63. 63.
    Simpson JL (1976) Disorders of sexual differentiation: etiology and clinical delineation. Monograph with chapters by J.E. Jirasek, N. G. Kase, and L. Speroff. Academic, New York, NYGoogle Scholar
  64. 64.
    Matthews CH, Borgato S, Beck-Peccoz P, Adams M, Tone Y, Gambino G, Casagrande S, Tedeschini G, Benedetti A, Chatterjee VK (1993) Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nat Genet 5:83–86PubMedGoogle Scholar
  65. 65.
    Layman LC, Amde S, Cohen DP, Jin M, Xie J (1998) The Finnish follicle-stimulating hormone receptor gene mutation is rare in North American women with 46,XX ovarian failure. Fertil Steril 69:300–302PubMedGoogle Scholar
  66. 66.
    Liu JY, Gromoll J, Cedars MI, La Barbera AR (1998) Identification of allelic variants in the follicle-stimulating hormone receptor genes of females with or without hypergonadotropic amenorrhea. Fertil Steril 70:326–331PubMedGoogle Scholar
  67. 67.
    Simoni M, Gromoll J, Nieschlag E (1997) The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 18:739–773PubMedGoogle Scholar
  68. 68.
    da Fonte Kohek MB, Batista MC, Russell AJ, Vass K, Giacaglia LR, Mendonca BB, Latronico AC (1998) No evidence of the inactivating mutation (C566T) in the follicle-stimulating hormone receptor gene in Brazilian women with premature ovarian failure. Fertil Steril 70:565–567PubMedGoogle Scholar
  69. 69.
    de la Chesnaye E, Canto P, Ulloa-Aguirre A, Mendez JP (2001) No evidence of mutations in the follicle-stimulating hormone receptor gene in Mexican women with 46, XX pure gonadal dysgenesis. Am J Med Genet 98:125–128PubMedGoogle Scholar
  70. 70.
    Touraine P, Beau I, Gougeon A, Meduri G, Desroches A, Pichard C, Detoeuf M, Paniel B, Prieur M, Zorn JR, Milgrom E, Kuttenn F, Misrahi M (1999) New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol Endocrinol 13:1844–1854PubMedGoogle Scholar
  71. 71.
    Sultan C, Lumbroso S (1998) LH receptor defects. In: Kempers RD, Cohen J, Haney AF, Younger JB (eds) Fertility and reproductive medicine - Proceedings of the XVI World congress on fertility and sterility. Elsevier Science, San Francisco, CAGoogle Scholar
  72. 72.
    Latronico AC, Chai Y, Arnhold IJ, Liu X, Mendonca BB, Segaloff DL (1998) A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol 12:442–450PubMedGoogle Scholar
  73. 73.
    Matzuk MM, Lamb DJ (2002) Genetic dissection of mammalian fertility pathways. Nat Cell Biol 4(Suppl):s41–49PubMedGoogle Scholar
  74. 74.
    Yanase T, Kagimoto M, Suzuki S, Hashiba K, Simpson ER, Waterman MR (1989) Deletion of a phenylalanine in the N-terminal region of human cytochrome P-450(17 alpha) results in partial combined 17 alpha-hydroxylase/17,20-lyase deficiency. J Biol Chem 264:18076–18082PubMedGoogle Scholar
  75. 75.
    Woad KJ, Pearson SM, Harris SE, Gersak K, Shelling AN (2009) Investigating the association between inhibin alpha gene promoter polymorphisms and premature ovarian failure. Fertil Steril 91:62–66PubMedGoogle Scholar
  76. 76.
    Shelling AN, Burton KA, Chand AL, van Ee CC, France JT, Farquhar CM, Milsom SR, Love DR, Gersak K, Aittomaki K, Winship IM (2000) Inhibin: a candidate gene for premature ovarian failure. Hum Reprod 15:2644–2649PubMedGoogle Scholar
  77. 77.
    Marozzi A, Porta C, Vegetti W, Crosignani PG, Tibiletti MG, Dalpra L, Ginelli E (2002) Mutation analysis of the inhibin alpha gene in a cohort of Italian women affected by ovarian failure. Hum Reprod 17:1741–1745PubMedGoogle Scholar
  78. 78.
    Dixit H, Deendayal M, Singh L (2004) Mutational analysis of the mature peptide region of inhibin genes in Indian women with ovarian failure. Hum Reprod 19:1760–1764PubMedGoogle Scholar
  79. 79.
    Prakash GJ, Ravi Kanth VV, Shelling AN, Rozati R, Sujatha M (2010) Mutational analysis of inhibin alpha gene revealed three novel variations in Indian women with premature ovarian failure. Fertil Steril 94:90–98PubMedGoogle Scholar
  80. 80.
    Shelling AN (2010) Premature ovarian failure. Reproduction 140:633–641PubMedGoogle Scholar
  81. 81.
    Chand AL, Ooi GT, Harrison CA, Shelling AN, Robertson DM (2007) Functional analysis of the human inhibin alpha subunit variant A257T and its potential role in premature ovarian failure. Hum Reprod 22:3241–3248PubMedGoogle Scholar
  82. 82.
    Chand AL, Harrison CA, Shelling AN (2010) Inhibin and premature ovarian failure. Hum Reprod Update 16:39–50PubMedGoogle Scholar
  83. 83.
    Dixit H, Rao LK, Padmalatha V, Kanakavalli M, Deenadayal M, Gupta N, Chakravarty B, Singh L (2005) Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause 12:749–754PubMedGoogle Scholar
  84. 84.
    Simsek E, Ozdemir I, Lin L, Achermann JC (2005) Isolated 17,20-lyase (desmolase) deficiency in a 46,XX female presenting with delayed puberty. Fertil Steril 83:1548–1551PubMedGoogle Scholar
  85. 85.
    Araki S, Chikazawa K, Sekiguchi I, Yamauchi H, Motoyama M, Tamada T (1987) Arrest of follicular development in a patient with 17 alpha-hydroxylase deficiency: folliculogenesis in association with a lack of estrogen synthesis in the ovaries. Fertil Steril 47:169–172PubMedGoogle Scholar
  86. 86.
    Rabinovici J, Blankstein J, Goldman B, Rudak E, Dor Y, Pariente C, Geier A, Lunenfeld B, Mashiach S (1989) In vitro fertilization and primary embryonic cleavage are possible in 17 alpha-hydroxylase deficiency despite extremely low intrafollicular 17 beta-estradiol. J Clin Endocrinol Metab 68:693–697PubMedGoogle Scholar
  87. 87.
    Simpson ER (1998) Genetic mutations resulting in estrogen insufficiency in the male. Mol Cell Endocrinol 145:55–59PubMedGoogle Scholar
  88. 88.
    Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER (1993) Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci U S A 90:11673–11677PubMedCentralPubMedGoogle Scholar
  89. 89.
    Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER (1994) A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab 78:1287–1292PubMedGoogle Scholar
  90. 90.
    Mullis PE, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H (1997) Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab 82:1739–1745PubMedGoogle Scholar
  91. 91.
    Mansouri MR, Schuster J, Badhai J, Stattin EL, Losel R, Wehling M, Carlsson B, Hovatta O, Karlstrom PO, Golovleva I, Toniolo D, Bione S, Peluso J, Dahl N (2008) Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure. Hum Mol Genet 17:3776–3783PubMedCentralPubMedGoogle Scholar
  92. 92.
    Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, Bisceglia L, Zelante L, Nagaraja R, Porcu S, Ristaldi MS, Marzella R, Rocchi M, Nicolino M, Lienhardt-Roussie A, Nivelon A, Verloes A, Schlessinger D, Gasparini P, Bonneau D, Cao A, Pilia G (2001) The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27:159–166PubMedGoogle Scholar
  93. 93.
    Harris SE, Chand AL, Winship IM, Gersak K, Aittomaki K, Shelling AN (2002) Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod 8:729–733PubMedGoogle Scholar
  94. 94.
    Gersak K, Harris SE, Smale WJ, Shelling AN (2004) A novel 30 bp deletion in the FOXL2 gene in a phenotypically normal woman with primary amenorrhoea: case report. Hum Reprod 19:2767–2770PubMedGoogle Scholar
  95. 95.
    De Baere E, Dixon MJ, Small KW, Jabs EW, Leroy BP, Devriendt K, Gillerot Y, Mortier G, Meire F, Van Maldergem L, Courtens W, Hjalgrim H, Huang S, Liebaers I, Van Regemorter N, Touraine P, Praphanphoj V, Verloes A, Udar N, Yellore V, Chalukya M, Yelchits S, De Paepe A, Kuttenn F, Fellous M, Veitia R, Messiaen L (2001) Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype–phenotype correlation. Hum Mol Genet 10:1591–1600PubMedGoogle Scholar
  96. 96.
    Qin Y, Choi Y, Zhao H, Simpson JL, Chen ZJ, Rajkovic A (2007) NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet 81:576–581PubMedCentralPubMedGoogle Scholar
  97. 97.
    Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA (2003) Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301:215–218Google Scholar
  98. 98.
    Chand AL, Ponnampalam AP, Harris SE, Winship IM, Shelling AN (2006) Mutational analysis of BMP15 and GDF9 as candidate genes for premature ovarian failure. Fertil Steril 86:1009–1012PubMedGoogle Scholar
  99. 99.
    Wang B, Wen Q, Ni F, Zhou S, Wang J, Cao Y, Ma X (2010) Analyses of growth differentiation factor 9 (GDF9) and bone morphogenetic protein 15 (BMP15) mutation in Chinese women with premature ovarian failure. Clin Endocrinol 72:135–136Google Scholar
  100. 100.
    Demirhan O, Turkmen S, Schwabe GC, Soyupak S, Akgul E, Tastemir D, Karahan D, Mundlos S, Lehmann K (2005) A homozygous BMPR1B mutation causes a new subtype of acromesomelic chondrodysplasia with genital anomalies. J Med Genet 42:314–317PubMedCentralPubMedGoogle Scholar
  101. 101.
    Yi SE, LaPolt PS, Yoon BS, Chen JY, Lu JK, Lyons KM (2001) The type I BMP receptor BmprIB is essential for female reproductive function. Proc Natl Acad Sci U S A 98:7994–7999PubMedCentralPubMedGoogle Scholar
  102. 102.
    Wilson T, Wu XY, Juengel JL, Ross IK, Lumsden JM, Lord EA, Dodds KG, Walling GA, McEwan JC, O’Connell AR, McNatty KP, Montgomery GW (2001) Highly prolific Booroola sheep have a mutation in the intracellular kinase domain of bone morphogenetic protein IB receptor (ALK-6) that is expressed in both oocytes and granulosa cells. Biol Reprod 64:1225–1235PubMedGoogle Scholar
  103. 103.
    Zhao H, Chen ZJ, Qin Y, Shi Y, Wang S, Choi Y, Simpson JL, Rajkovic A (2008) Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am J Hum Genet 82:1342–1348PubMedCentralPubMedGoogle Scholar
  104. 104.
    Wang J, Wang B, Song J, Suo P, Ni F, Chen B, Ma X, Cao Y (2011) New candidate gene POU5F1 associated with premature ovarian failure in Chinese patients. Reprod Biomed Online 22:312–316PubMedGoogle Scholar
  105. 105.
    Kang H, Lee SK, Kim MH, Song J, Bae SJ, Kim NK, Lee SH, Kwack K (2008) Parathyroid hormone-responsive B1 gene is associated with premature ovarian failure. Hum Reprod 23:1457–1465PubMedGoogle Scholar
  106. 106.
    Kaufman FR, Kogut MD, Donnell GN, Goebelsmann U, March C, Koch R (1981) Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 304:994–998PubMedGoogle Scholar
  107. 107.
    Waggoner DD, Buist NR, Donnell GN (1990) Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inher Metab Dis 13:802–818PubMedGoogle Scholar
  108. 108.
    Levy HL, Driscoll SG, Porensky RS, Wender DF (1984) Ovarian failure in galactosemia. N Engl J Med 310:50PubMedGoogle Scholar
  109. 109.
    Leslie ND, Yager KL, McNamara PD, Segal S (1996) A mouse model of galactose-1-phosphate uridyl transferase deficiency. Biochem Mol Med 59:7–12PubMedGoogle Scholar
  110. 110.
    Badik JR, Castaneda U, Gleason TJ, Spencer JB, Epstein MP, Ficicioglu C, Fitzgerald K, Fridovich-Keil JL (2011) Ovarian function in Duarte galactosemia. Fertil Steril 96(469–473):e461Google Scholar
  111. 111.
    Bjursell C, Stibler H, Wahlstrom J, Kristiansson B, Skovby F, Stromme P, Blennow G, Martinsson T (1997) Fine mapping of the gene for carbohydrate-deficient glycoprotein syndrome, type I (CDG1): linkage disequilibrium and founder effect in Scandinavian families. Genomics 39:247–253PubMedGoogle Scholar
  112. 112.
    Matthijs G, Schollen E, Pardon E, Veiga-Da-Cunha M, Jaeken J, Cassiman JJ, Van Schaftingen E (1997) Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet 16:88–92PubMedGoogle Scholar
  113. 113.
    de Zegher F, Jaeken J (1995) Endocrinology of the carbohydrate-deficient glycoprotein syndrome type 1 from birth through adolescence. Pediatr Res 37:395–401PubMedGoogle Scholar
  114. 114.
    Kristiansson B, Stibler H, Wide L (1995) Gonadal function and glycoprotein hormones in the carbohydrate-deficient glycoprotein (CDG) syndrome. Acta Paediatr 84:655–659PubMedGoogle Scholar
  115. 115.
    Wang CY, Davoodi-Semiromi A, Huang W, Connor E, Shi JD, She JX (1998) Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APS1). Hum Genet 103:681–685PubMedGoogle Scholar
  116. 116.
    Boltshauser E, Barth PG, Troost D, Martin E, Stallmach T (2002) “Vanishing white matter” and ovarian dysgenesis in an infant with cerebro-oculo-facio-skeletal phenotype. Neuropediatrics 33:57–62PubMedGoogle Scholar
  117. 117.
    Schiffmann R, Tedeschi G, Kinkel RP, Trapp BD, Frank JA, Kaneski CR, Brady RO, Barton NW, Nelson L, Yanovski JA (1997) Leukodystrophy in patients with ovarian dysgenesis. Ann Neurol 41:654–661PubMedGoogle Scholar
  118. 118.
    Fogli A, Rodriguez D, Eymard-Pierre E, Bouhour F, Labauge P, Meaney BF, Zeesman S, Kaneski CR, Schiffmann R, Boespflug-Tanguy O (2003) Ovarian failure related to eukaryotic initiation factor 2B mutations. Am J Hum Genet 72:1544–1550PubMedCentralPubMedGoogle Scholar
  119. 119.
    Fogli A, Gauthier-Barichard F, Schiffmann R, Vanderhoof VH, Bakalov VK, Nelson LM, Boespflug-Tanguy O (2004) Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure. BMC Womens Health 4:8PubMedCentralPubMedGoogle Scholar
  120. 120.
    Skre H, Bassoe HH, Berg K, Frovig AG (1976) Cerebellar ataxia and hypergonadotropic hypogonadism in two kindreds. Chance concurrence, pleiotropism or linkage? Clin Genet 9:234–244PubMedGoogle Scholar
  121. 121.
    De Michele G, Filla A, Striano S, Rimoldi M, Campanella G (1993) Heterogeneous findings in four cases of cerebellar ataxia associated with hypogonadism (Holmes’ type ataxia). Clin Neurol Neurosurg 95:23–28PubMedGoogle Scholar
  122. 122.
    Linssen WH, Van den Bent MJ, Brunner HG, Poels PJ (1994) Deafness, sensory neuropathy, and ovarian dysgenesis: a new syndrome or a broader spectrum of Perrault syndrome? Am J Med Genet 51:81–82PubMedGoogle Scholar
  123. 123.
    Amor DJ, Delatycki MB, Gardner RJ, Storey E (2001) New variant of familial cerebellar ataxia with hypergonadotropic hypogonadism and sensorineural deafness. Am J Med Genet 99:29–33PubMedGoogle Scholar
  124. 124.
    Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Belmonte JC, Choe S (2002) Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature 420:636–642PubMedGoogle Scholar
  125. 125.
    Kosaki K, Sato S, Hasegawa T, Matsuo N, Suzuki T, Ogata T (2004) Premature ovarian failure in a female with proximal symphalangism and Noggin mutation. Fertil Steril 81:1137–1139PubMedGoogle Scholar
  126. 126.
    Perrault M, Klotz P, Housset E (1951) Deux cas de syndrome de Turner avec surdi-mutite dans une meme fratrie. Bull Mem Soc Med Hop Paris 67:79–84PubMedGoogle Scholar
  127. 127.
    Josso N, de Grouchy J, Frezal J, Lamy M (1963) Le syndrome de Turner familial etude de deux families avec caryotypes XO er XX. Ann Pediatr 10:163–167Google Scholar
  128. 128.
    Nishi Y, Hamamoto K, Kajiyama M, Kawamura I (1988) The Perrault syndrome: clinical report and review. Am J Med Genet 31:623–629PubMedGoogle Scholar
  129. 129.
    Pallister PD, Opitz JM (1979) The Perrault syndrome: autosomal recessive ovarian dysgenesis with facultative, non-sex-limited sensorineural deafness. Am J Med Genet 4:239–246PubMedGoogle Scholar
  130. 130.
    Simon AM, Goodenough DA, Li E, Paul DL (1997) Female infertility in mice lacking connexin 37. Nature 385:525–529PubMedGoogle Scholar
  131. 132.
    Watkins WJ, Umbers AJ, Woad KJ, Harris SE, Winship IM, Gersak K, Shelling AN (2006) Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure. Fertil Steril 86:1518–1521PubMedGoogle Scholar
  132. 133.
    Wang B, Mu Y, Ni F, Zhou S, Wang J, Cao Y, Ma X (2010) Analysis of FOXO3 mutation in 114 Chinese women with premature ovarian failure. Reprod Biomed Online 20:499–503PubMedGoogle Scholar
  133. 134.
    Pangas SA, Choi Y, Ballow DJ, Zhao Y, Westphal H, Matzuk MM, Rajkovic A (2006) Oogenesis requires germ cell-specific transcriptional regulators Sohlh1 and Lhx8. Proc Natl Acad Sci U S A 103:8090–8095PubMedCentralPubMedGoogle Scholar
  134. 135.
    Qin Y, Zhao H, Kovanci E, Simpson JL, Chen ZJ, Rajkovic A (2008) Analysis of LHX8 mutation in premature ovarian failure. Fertil Steril 89:1012–1014PubMedCentralPubMedGoogle Scholar
  135. 136.
    Tsuda M, Sasaoka Y, Kiso M, Abe K, Haraguchi S, Kobayashi S, Saga Y (2003) Conserved role of nanos proteins in germ cell development. Science 301:1239–1241PubMedGoogle Scholar
  136. 137.
    Qin Y, Zhao H, Kovanci E, Simpson JL, Chen ZJ, Rajkovic A (2007) Mutation analysis of NANOS3 in 80 Chinese and 88 Caucasian women with premature ovarian failure. Fertil Steril 88:1465–1467PubMedCentralPubMedGoogle Scholar
  137. 138.
    Mehlmann LM, Saeki Y, Tanaka S, Brennan TJ, Evsikov AV, Pendola FL, Knowles BB, Eppig JJ, Jaffe LA (2004) The Gs-linked receptor GPR3 maintains meiotic arrest in mammalian oocytes. Science 306:1947–1950PubMedGoogle Scholar
  138. 139.
    Kovanci E, Simpson JL, Amato P, Rohozinski J, Heard MJ, Bishop CE, Carson SA (2008) Oocyte-specific G-protein-coupled receptor 3 (GPR3): no perturbations found in 82 women with premature ovarian failure (first report). Fertil Steril 90:1269–1271PubMedGoogle Scholar
  139. 140.
    Zhou S, Wang B, Ni F, Wang J, Cao Y, Ma X (2010) GPR3 may not be a potential candidate gene for premature ovarian failure. Reprod Biomed Online 20:53–55PubMedGoogle Scholar
  140. 141.
    Richards KA, Fukai K, Oiso N, Paller AS (2001) A novel KIT mutation results in piebaldism with progressive depigmentation. J Am Acad Dermatol 44:288–292PubMedGoogle Scholar
  141. 142.
    Shibanuma K, Tong ZB, Vanderhoof VH, Vanevski K, Nelson LM (2002) Investigation of KIT gene mutations in women with 46,XX spontaneous premature ovarian failure. BMC Womens Health 2:8PubMedCentralPubMedGoogle Scholar
  142. 143.
    Suzumori N, Burns KH, Yan W, Matzuk MM (2003) RFPL4 interacts with oocyte proteins of the ubiquitin-proteasome degradation pathway. Proc Natl Acad Sci U S A 100:550–555PubMedCentralPubMedGoogle Scholar
  143. 144.
    Suzumori N, Pangas SA, Rajkovic A (2007) Candidate genes for premature ovarian failure. Curr Med Chem 14:353–357PubMedGoogle Scholar
  144. 145.
    Mandon-Pepin B, Touraine P, Kuttenn F, Derbois C, Rouxel A, Matsuda F, Nicolas A, Cotinot C, Fellous M (2008) Genetic investigation of four meiotic genes in women with premature ovarian failure. Eur J Endocrinol 158:107–115PubMedGoogle Scholar
  145. 146.
    Shimizu Y, Kimura F, Takebayashi K, Fujiwara M, Takakura K, Takahashi K (2009) Mutational analysis of the PTEN gene in women with premature ovarian failure. Acta Obstet Gynecol Scand 88:824–825PubMedGoogle Scholar
  146. 147.
    Ojeda D, Lakhal B, Fonseca DJ, Braham R, Landolsi H, Mateus HE, Restrepo CM, Elghezal H, Saad A, Laissue P (2011) Sequence analysis of the CDKN1B gene in patients with premature ovarian failure reveals a novel mutation potentially related to the phenotype. Fertil Steril 95(2658–2660):e2651Google Scholar
  147. 148.
    Wang B, Ni F, Li L, Wei Z, Zhu X, Wang J, Cao Y, Ma X (2010) Analysis of cyclin-dependent kinase inhibitor 1B mutation in Han Chinese women with premature ovarian failure. Reprod Biomed Online 21:212–214PubMedGoogle Scholar
  148. 149.
    Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP (1999) Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 140:5789–5796PubMedGoogle Scholar
  149. 150.
    Wang HQ, Takakura K, Takebayashi K, Noda Y (2002) Mutational analysis of the mullerian-inhibiting substance gene and its receptor gene in Japanese women with polycystic ovary syndrome and premature ovarian failure. Fertil Steril 78:1329–1330PubMedGoogle Scholar
  150. 151.
    Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM, Oldfors A, Rautakorpi I, Peltonen L, Majamaa K, Somer H, Suomalainen A (2004) Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364:875–882PubMedGoogle Scholar
  151. 152.
    Pagnamenta AT, Taanman JW, Wilson CJ, Anderson NE, Marotta R, Duncan AJ, Bitner-Glindzicz M, Taylor RW, Laskowski A, Thorburn DR, Rahman S (2006) Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma. Hum Reprod 21:2467–2473PubMedGoogle Scholar
  152. 153.
    Granat M, Amar A, Mor-Yosef S, Brautbar C, Schenker JG (1983) Familial gonadal germinative failure: endocrine and human leukocyte antigen studies. Fertil Steril 40:215–219PubMedGoogle Scholar
  153. 154.
    Smith A, Fraser IS, Noel M (1979) Three siblings with premature gonadal failure. Fertil Steril 32:528–530PubMedGoogle Scholar
  154. 155.
    Al-Awadi SA, Farag TI, Teebi AS, Naguib K, el-Khalifa MY, Kelani Y, Al-Ansari A, Schimke RN (1985) Primary hypogonadism and partial alopecia in three sibs with mullerian hypoplasia in the affected females. Am J Med Genet 22:619–622PubMedGoogle Scholar
  155. 156.
    Mikati MA, Najjar SS, Sahli IF, Melhem RE, Mansour S, Der Kaloustian VM (1985) Microcephaly, hypergonadotropic hypogonadism, short stature, and minor anomalies: a new syndrome. Am J Med Genet 22:599–608PubMedGoogle Scholar
  156. 157.
    Simpson JL (1999) Genetics of the female reproductive ducts. Am J Med Genet 89:224–239PubMedGoogle Scholar
  157. 158.
    Elias S, Simpson JL, Carson SA, Malinak LR, Buttram VC Jr (1984) Genetics studies in incomplete mullerian fusion. Obstet Gynecol 63:276–279PubMedGoogle Scholar
  158. 159.
    Ergun A, Pabuccu R, Atay V, Kucuk T, Duru NK, Gungor S (1997) Three sisters with septate uteri: another reference to bidirectional theory. Hum Reprod 12:140–142PubMedGoogle Scholar
  159. 160.
    Hay D (1961) Uterus unicollis and its relationship to pregnancy. J Obstet Gynaecol Br Emp 68:361–377PubMedGoogle Scholar
  160. 161.
    Holmes JA (1956) Congenital abnormalities of the uterus and pregnancy. Br Med J 1:1144–1147PubMedCentralPubMedGoogle Scholar
  161. 162.
    Nykiforuk NE (1938) Uterus Didelphys. Can Med Assoc J 38:175PubMedCentralPubMedGoogle Scholar
  162. 163.
    Polishuk WZ, Ron MA (1974) Familial bicornuate and double uterus. Am J Obstet Gynecol 119:982–987PubMedGoogle Scholar
  163. 164.
    Stevenson AC, Dudgeon MY, Mc CH (1959) Observations on the results of pregnancies in women resident in Belfast. II. Abortions, hydatidiform moles and ectopic pregnancies. Ann Hum Genet 23:395–414PubMedGoogle Scholar
  164. 165.
    Tyler GT (1939) Didelphys, in sisters. Am J Surg 45:337–338Google Scholar
  165. 166.
    Verp MS, Simpson JL, Elias S, Carson SA, Sarto GE, Feingold M (1983) Heritable aspects of uterine anomalies. I. Three familial aggregates with Mullerian fusion anomalies. Fertil Steril 40:80–85PubMedGoogle Scholar
  166. 167.
    Way S (1945) The influence of minor degrees of failure of fusion of the Mullerian ducts on pregnancy and labor. J Obstet Gynaecol Br Emp 52:325–333Google Scholar
  167. 168.
    Ma J, Qin Y, Liu W, Duan H, Xia M, Chen ZJ (2011) Analysis of PBX1 mutations in 192 Chinese women with Mullerian duct abnormalities. Fertil Steril 95:2615–2617PubMedGoogle Scholar
  168. 169.
    Schnabel CA, Selleri L, Cleary ML (2003) Pbx1 is essential for adrenal development and urogenital differentiation. Genesis 37:123–130PubMedGoogle Scholar
  169. 170.
    Donnenfeld AE, Schrager DS, Corson SL (1992) Update on a family with hand-foot-genital syndrome: hypospadias and urinary tract abnormalities in two boys from the fourth generation. Am J Med Genet 44:482–484PubMedGoogle Scholar
  170. 171.
    Stern AM, Gall JC Jr, Perry BL, Stimson CW, Weitkamp LR, Poznanski AK (1970) The hand-food-uterus syndrome: a new hereditary disorder characterized by hand and foot dysplasia, dermatoglyphic abnormalities, and partial duplication of the female genital tract. J Pediatr 77:109–116PubMedGoogle Scholar
  171. 172.
    Mortlock DP, Innis JW (1997) Mutation of HOXA13 in hand-foot-genital syndrome. Nat Genet 15:179–180PubMedGoogle Scholar
  172. 173.
    Goodman FR, Bacchelli C, Brady AF, Brueton LA, Fryns JP, Mortlock DP, Innis JW, Holmes LB, Donnenfeld AE, Feingold M, Beemer FA, Hennekam RC, Scambler PJ (2000) Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am J Hum Genet 67:197–202PubMedCentralPubMedGoogle Scholar
  173. 174.
    Hennekam RC (1989) Acral-genital anomalies combined with ear anomalies. Am J Med Genet 34:454–455PubMedGoogle Scholar
  174. 175.
    Utsch B, Becker K, Brock D, Lentze MJ, Bidlingmaier F, Ludwig M (2002) A novel stable polyalanine [poly(A)] expansion in the HOXA13 gene associated with hand-foot-genital syndrome: proper function of poly(A)-harbouring transcription factors depends on a critical repeat length? Hum Genet 110:488–494PubMedGoogle Scholar
  175. 176.
    Jones HW Jr, Rock JA (1983) Reparative and constructive surgery of the female genital tract. Williams & Wilkins, BaltimoreGoogle Scholar
  176. 177.
    Lodi A (1951) Contributo clinco statistico sulle Malformazioni della vagina osservate nella Clinical Obstetrica e Gineocologica di Milano del 1906 al 1950. Ann Ostet Ginecol 73:1246–1285PubMedGoogle Scholar
  177. 178.
    McKusick VA (1978) The William Allan Memorial Award Lecture: Genetic nosology: three approaches. Am J Hum Genet 30:105–122PubMedCentralPubMedGoogle Scholar
  178. 179.
    McKusick VA, Bauer RL, Koop CE, Scott RB (1964) Hydrometrocolpos as a Simply Inherited Malformation. JAMA 189:813–816PubMedGoogle Scholar
  179. 180.
    Kaufman RL, McAlister WH, Ho CK, Hartmann AF (1974) Family studies in congenital heart disease VI. The association of severe obstructive left heart lesions, vertebral and renal anomalies; a second family. Birth Defects Orig Artic Ser 10:93–104PubMedGoogle Scholar
  180. 181.
    Chitayat D, Hahm SY, Marion RW, Sachs GS, Goldman D, Hutcheon RG, Weiss R, Cho S, Nitowsky HM (1987) Further delineation of the McKusick-Kaufman hydrometrocolpos-polydactyly syndrome. Am J Dis Child 141:1133–1136PubMedGoogle Scholar
  181. 182.
    Stone DL, Slavotinek A, Bouffard GG, Banerjee-Basu S, Baxevanis AD, Barr M, Biesecker LG (2000) Mutation of a gene encoding a putative chaperonin causes McKusick-Kaufman syndrome. Nat Genet 25:79–82PubMedGoogle Scholar
  182. 183.
    Winter JS, Kohn G, Mellman WJ, Wagner S (1968) A familial syndrome of renal, genital, and middle ear anomalies. J Pediatr 72:88–93PubMedGoogle Scholar
  183. 184.
    King LA, Sanchez-Ramos L, Talledo OE, Reindollar RH (1987) Syndrome of genital, renal, and middle ear anomalies: a third family and report of a pregnancy. Obstet Gynecol 69:491–493PubMedGoogle Scholar
  184. 185.
    Griffin JE, Edwards C, Madden JD, Harrod MJ, Wilson JD (1976) Congenital absence of the vagina. The Mayer-Rokitansky-Kuster-Hauser syndrome. Ann Intern Med 85:224–236PubMedGoogle Scholar
  185. 186.
    Jones HW Jr, Mermut S (1972) Familial occurrence of congenital absence of the vagina. Am J Obstet Gynecol 114:1100–1101PubMedGoogle Scholar
  186. 187.
    Kupperman JH (1963) Human endocrinology, vol 1. FA Davis, Philadelphia, PAGoogle Scholar
  187. 188.
    Lischke JH, Curtis CH, Lamb EJ (1973) Discordance of vaginal agenesis in monozygotic twins. Obstet Gynecol 41:920–924PubMedGoogle Scholar
  188. 189.
    Carson SA, Simpson JL, Malinak LR, Elias S, Gerbie AB, Buttram VC Jr, Sarto GE (1983) Heritable aspects of uterine anomalies. II. Genetic analysis of Mullerian aplasia. Fertil Steril 40:86–90PubMedGoogle Scholar
  189. 190.
    van Lingen BL, Reindollar RH, Davis AJ, Gray MR (1998) Further evidence that the WT1 gene does not have a role in the development of the derivatives of the mullerian duct. Am J Obstet Gynecol 179:597–603PubMedGoogle Scholar
  190. 191.
    Petrozza JC, Gray MR, Davis AJ, Reindollar RH (1997) Congenital absence of the uterus and vagina is not commonly transmitted as a dominant genetic trait: outcomes of surrogate pregnancies. Fertil Steril 67:387–389PubMedGoogle Scholar
  191. 192.
    Van Lingen BL, Eccles MR, Reindollar RH, al E. (1998) Molecular genetic analysis of the PAX2 gene in patients with gengenital absence of the uterus and vagina., Fertil Steril.Google Scholar
  192. 193.
    Zenteno JC, Carranza-Lira S, Kofman-Alfaro S (2004) Molecular analysis of the anti-Mullerian hormone, the anti-Mullerian hormone receptor, and galactose-1-phosphate uridyl transferase genes in patients with the Mayer-Rokitansky-Kuster-Hauser syndrome. Arch Gynecol Obstet 269:270–273PubMedGoogle Scholar
  193. 194.
    Bhagavath B, Stelling JR, Van Lingen BL et al (1998) Congenital absence of the uterus and vagina (CAUV) is not associated with the N314D allele of the galactose-1-phosphate uridyl transferase (GALT) gene. J Soc Gynecol Investig 5:140Google Scholar
  194. 195.
    Cheroki C, Krepischi-Santos AC, Rosenberg C, Jehee FS, Mingroni-Netto RC, Pavanello Filho I, Zanforlin Filho S, Kim CA, Bagnoli VR, Mendonca BB, Szuhai K, Otto PA (2006) Report of a del22q11 in a patient with Mayer-Rokitansky-Kuster-Hauser (MRKH) anomaly and exclusion of WNT-4, RAR-gamma, and RXR-alpha as major genes determining MRKH anomaly in a study of 25 affected women. Am J Med Genet A 140:1339–1342PubMedGoogle Scholar
  195. 196.
    Burel A, Mouchel T, Odent S, Tiker F, Knebelmann B, Pellerin I, Guerrier D (2006) Role of HOXA7 to HOXA13 and PBX1 genes in various forms of MRKH syndrome (congenital absence of uterus and vagina). J Negat Results Biomed 5:4PubMedCentralPubMedGoogle Scholar
  196. 197.
    Philibert P, Biason-Lauber A, Rouzier R, Pienkowski C, Paris F, Konrad D, Schoenle E, Sultan C (2008) Identification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and mullerian duct abnormalities: a French collaborative study. J Clin Endocrinol Metab 93:895–900PubMedGoogle Scholar
  197. 198.
    Ravel C, Lorenco D, Dessolle L, Mandelbaum J, McElreavey K, Darai E, Siffroi JP (2009) Mutational analysis of the WNT gene family in women with Mayer-Rokitansky-Kuster-Hauser syndrome. Fertil Steril 91:1604–1607PubMedGoogle Scholar
  198. 199.
    Drash A, Sherman F, Hartmann WH, Blizzard RM (1970) A syndrome of pseudohermaphroditism, Wilms’ tumor, hypertension, and degenerative renal disease. J Pediatr 76:585–593PubMedGoogle Scholar
  199. 200.
    Clement-Ziza M, Khen N, Gonzales J, Cretolle-Vastel C, Picard JY, Tullio-Pelet A, Besmond C, Munnich A, Lyonnet S, Nihoul-Fekete C (2005) Exclusion of WNT4 as a major gene in Rokitansky-Kuster-Hauser anomaly. Am J Med Genet A 137:98–99PubMedGoogle Scholar
  200. 201.
    Sandbacka M, Bruce S, Halttunen M, Puhakka M, Lahermo P, Hannula-Jouppi K, Lipsanen-Nyman M, Kere J, Aittomaki K, Laivuori H (2011) Methylation of H19 and its imprinted control region (H19 ICR1) in Mullerian aplasia. Fertil Steril 95:2703–2706PubMedGoogle Scholar
  201. 202.
    Bendavid C, Pasquier L, Watrin T, Morcel K, Lucas J, Gicquel I, Dubourg C, Henry C, David V, Odent S, Leveque J, Pellerin I, Guerrier D (2007) Phenotypic variability of a 4q34→qter inherited deletion: MRKH syndrome in the daughter, cardiac defect and Fallopian tube cancer in the mother. Eur J Med Genet 50:66–72PubMedGoogle Scholar
  202. 203.
    Bernardini L, Gimelli S, Gervasini C, Carella M, Baban A, Frontino G, Barbano G, Divizia MT, Fedele L, Novelli A, Bena F, Lalatta F, Miozzo M, Dallapiccola B (2009) Recurrent microdeletion at 17q12 as a cause of Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome: two case reports. Orphanet J Rare Dis 4:25PubMedCentralPubMedGoogle Scholar
  203. 204.
    Cheroki C, Krepischi-Santos AC, Szuhai K, Brenner V, Kim CA, Otto PA, Rosenberg C (2008) Genomic imbalances associated with mullerian aplasia. J Med Genet 45:228–232PubMedGoogle Scholar
  204. 205.
    Ledig S, Schippert C, Strick R, Beckmann MW, Oppelt PG, Wieacker P (2011) Recurrent aberrations identified by array-CGH in patients with Mayer-Rokitansky-Kuster-Hauser syndrome. Fertil Steril 95:1589–1594PubMedGoogle Scholar
  205. 206.
    Nik-Zainal S, Strick R, Storer M, Huang N, Rad R, Willatt L, Fitzgerald T, Martin V, Sandford R, Carter NP, Janecke AR, Renner SP, Oppelt PG, Oppelt P, Schulze C, Brucker S, Hurles M, Beckmann MW, Strissel PL, Shaw-Smith C (2011) High incidence of recurrent copy number variants in patients with isolated and syndromic Mullerian aplasia. J Med Genet 48:197–204PubMedCentralPubMedGoogle Scholar
  206. 207.
    Sundaram UT, McDonald-McGinn DM, Huff D, Emanuel BS, Zackai EH, Driscoll DA, Bodurtha J (2007) Primary amenorrhea and absent uterus in the 22q11.2 deletion syndrome. Am J Med Genet A 143A:2016–2018PubMedCentralPubMedGoogle Scholar
  207. 208.
    Gervasini C, Grati FR, Lalatta F, Tabano S, Gentilin B, Colapietro P, De Toffol S, Frontino G, Motta F, Maitz S, Bernardini L, Dallapiccola B, Fedele L, Larizza L, Miozzo M (2010) SHOX duplications found in some cases with type I Mayer-Rokitansky-Kuster-Hauser syndrome. Genet Med 12:634–640PubMedGoogle Scholar
  208. 209.
    Sandbacka M, Halttunen M, Jokimaa V, Aittomaki K, Laivuori H (2011) Evaluation of SHOX copy number variations in patients with Mullerian aplasia. Orphanet J Rare Dis 6:53PubMedCentralPubMedGoogle Scholar
  209. 210.
    Biason-Lauber A, Konrad D, Navratil F, Schoenle EJ (2004) A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46,XX woman. N Engl J Med 351:792–798PubMedGoogle Scholar
  210. 211.
    Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP (1999) Female development in mammals is regulated by Wnt-4 signalling. Nature 397:405–409PubMedGoogle Scholar
  211. 212.
    Duncan PA, Shapiro LR, Stangel JJ, Klein RM, Addonizio JC (1979) The MURCS association: Mullerian duct aplasia, renal aplasia, and cervicothoracic somite dysplasia. J Pediatr 95:399–402PubMedGoogle Scholar
  212. 213.
    Wulfsberg EA, Grigbsy TM (1990) Rokitansky sequence in association with the facio-auriculo-vertebral sequence: part of a mesodermal malformation spectrum? Am J Med Genet 37:100–102PubMedGoogle Scholar
  213. 214.
    Farag TI, Al-Awadi SA, Marafie MJ, Bastaki L, Al-Othman SA, Mohammed FM, Al Suliman IS, Murthy DS (1993) The newly recognised limb/pelvis-hypoplasia/aplasia syndrome: report of a Bedouin patient and review. J Med Genet 30:62–64PubMedCentralPubMedGoogle Scholar
  214. 215.
    Teebi AS (1993) Limb/pelvis/uterus-hypoplasia/aplasia syndrome. J Med Genet 30:797PubMedCentralPubMedGoogle Scholar
  215. 216.
    Hoffmann W, Grospietsch G, Kuhn W (1976) Thalidomide and female genital malformations. Lancet 2:794PubMedGoogle Scholar
  216. 217.
    Griesinger G, Dafopoulos K, Schultze-Mosgau A, Schroder A, Felberbaum R, Diedrich K (2005) Mayer-Rokitansky-Kuster-Hauser syndrome associated with thrombocytopenia-absent radius syndrome. Fertil Steril 83:452–454PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of Human and Molecular GeneticsHerbert Wertheim College of Medicine, Florida International UniversityMiamiUSA
  2. 2.Department of Obstetrics and GynecologyHerbert Wertheim College of Medicine, Florida International UniversityMiamiUSA

Personalised recommendations